Many are split on whether AI is good for humanity, but a new AI-powered tool could prove revolutionary when it comes to ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...

Cancer cells release tiny biological packages called extracellular vesicles (EVs) that help tumors grow and spread. A team ...

Zeaxanthin, a substance found in green vegetables and known for eye health, has been discovered to have the potential to ...

Converge Bio, the Generative AI Lab for the Life Sciences, shares findings from a new study showing that ConvergeAB™, their antibody design and optimization solution, was able to improve cetuximab, a ...

IBRX's Q1 outlook rides on Anktiva's surging uptake, with preliminary revenues showing triple-digit growth ahead of its ...

Janux Therapeutics, Inc. upgraded to Strong Buy: below cash value, strong runway, TRACTr progress, Merck/BMY milestones.

In a recent study published in Genes & Diseases, researchers from Chinese Academy of Medical Sciences and Peking Union Medical College, Capital ...

Summit Therapeutics posts narrower Q1 loss but stock plunges 25% after ivonescimab setback, raising concerns over its late-stage cancer pipeline progress.

Researchers have found that microglia in Alzheimer’s patients carry cancer-associated mutations, some also present in blood cells, suggesting these altered immune cells may infiltrate the brain and ...

Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today announced the ...

Iterion Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for Wnt/?-catenin-driven cancers, today announced that tegavivint, a first-in-class small-molecule inhibitor ...